FDA Permits Production Of Generic Heroin Drug Against Bid Of Reckitt

February 27, 2013

Two generic forms of Reckitt Benckiser’s heroin addiction medication have been approved by U.S. regulators, rejecting the company’s bid to prevent rival products based on their belief that stricter regulations were needed on packages to better protect children. Reckitt Benckiser, a British consumer health products company, makes a good portion of its earnings from Suboxone, […]

Read the full article →

SUBOXONE (Buprenorphine Hydrochloride, Naloxone Hydrochloride) Tablet [Reckitt Benckiser Pharmaceuticals Inc.]

February 24, 2013

Updated Date: Feb 22, 2013 EST (Source: DailyMed Drug Label Updates for the last seven days (since May 20, 2007 EST)) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Read the full article →

Overcome Opiate Addiction with the 12 Month Comprehensive Outpatient…

February 15, 2013

Five Points Wellness and Recovery: A 12-Month Bio-Psycho-Social Intensive Outpatient Treatment Program Utilizing Suboxone, Psychotherapy, Wellness and Occupational Support(PRWeb February 13, 2013)Read the full story at http://www.prweb.com/releases/2013/2/prweb10419052.htm (Source: PRWeb: Medical Pharmaceuticals) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Read the full article →

Glaxosmithkline Raises Stake in Indian Business While Reckitt Shakes of suboxone worries

February 6, 2013

From Guardian Web (February 5, 2013) Ahead of its results on Wednesday, GlaxoSmithKline has successfully raised its stake in its Indian consumer subsidiary. The company is paying £568m to take its shareholding in the business – whose… (Source: Drugs.com – Pharma News) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm […]

Read the full article →

Glaxosmithkline Raises Stake in Indian Business While Reckitt Shakes of suboxone worries

February 6, 2013

From Guardian Web (February 5, 2013) Ahead of its results on Wednesday, GlaxoSmithKline has successfully raised its stake in its Indian consumer subsidiary. The company is paying £568m to take its shareholding in the business – whose… (Source: Drugs.com – Pharma News) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm […]

Read the full article →

Notes from the field: emergency department visits and hospitalizations for buprenorphine ingestion by children – United States, 2010-2011 –

January 26, 2013

Buprenorphine (Subutex) and buprenorphine/naloxone (Suboxone) received Food and Drug Administration approval in 2002 for the treatment of opioid dependence. Introduction of these drugs expanded the availability of opioid-dependence treatment options to red… (Source: SafetyLit: All (Unduplicated)) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the […]

Read the full article →

Table of Contents

January 25, 2013

Discussion in New Hampshire Addiction Services for People with Developmental Disabilities No Evidence of Liver Toxicity from Suboxone or Methadone Briefly Noted State News Resources Coming up (Source: Alcoholism and Drug Abuse Weekly) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news […]

Read the full article →

Buprenorphine/naloxone: Death in an infant: case report

January 20, 2013

(Source: Reactions) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Read the full article →

Buprenorphine/naloxone: Death in an infant: case report

January 20, 2013

(Source: Reactions) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest addiction news and research.

Read the full article →

Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: A randomized trial

January 15, 2013

Conclusions: This study demonstrated no evidence of liver damage during the initial 6 months of treatment in either condition. Physicians can prescribe either medication without major concern for liver injury. (Source: Drug and Alcohol Dependence) MedWorm Sponsor Message: Have a look at The Addiction Daily, the new MedWorm portal, updated daily with all the latest […]

Read the full article →

← Previous Entries

Next Entries →